C. Gill

Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.

J. Radford, P. Wilkinson, J. Chang, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A study of ovarian cancer patients treated with dose-intensive chemotherapy supported with peripheral blood progenitor cells mobilised by filgrastim and cyclophosphamide.

J. Chang, D. Crowther, T. Dexter, 1996, British Journal of Cancer.

Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.

R. Brunkhorst, J. Wagner, J. Bommer, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increased Numbers of Progenitor Cells in the Apheresis Product of Patients Randomised to Receive Increasing Doses of Stem Cell Factor (r-metHuSCF) Administered in Combination with Chemotherapy and a Standard Dose of Filgrastim (r-metHuG-CSF)

D. Crowther, T. Dexter, P. Woll, 1998 .

Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome

J. Fitzgerald, A. Lerner, S. Beqaj, 2010 .

Molecular and epidemiological approaches to the etiology of urinary tract tumors in an area with Balkan endemic nephropathy.

M. Castegnaro, I. Chernozemsky, I. Nikolov, 1996, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

REVIEW OF THE COOPERATIVE STUDIES OF THE NATIONAL ONCOLOGICAL CENTRE IN BULGARIA ON BALKAN ENDEMIC NEPHROPATHY AND ASSOCIATED URINARY TRACT TUMOURS (1991 - 2001)

R. Dietrich, E. Märtlbauer, T. Vrabcheva, 2002 .